Your browser doesn't support javascript.
loading
High RIPK3 expression is associated with a higher risk of early kidney transplant failure.
Wahida, Adam; Schmaderer, Christoph; Büttner-Herold, Maike; Branca, Caterina; Donakonda, Sainitin; Haberfellner, Flora; Torrez, Carlos; Schmitz, Jessica; Schulze, Tobias; Seibt, Tobias; Öllinger, Rupert; Engleitner, Thomas; Haller, Bernhard; Steiger, Katja; Günthner, Roman; Lorenz, Georg; Yabal, Monica; Bachmann, Quirin; Braunisch, Matthias C; Moog, Philipp; Matevossian, Edouard; Aßfalg, Volker; Thorban, Stefan; Renders, Lutz; Späth, Martin R; Müller, Roman-Ulrich; Stippel, Dirk L; Weichert, Wilko; Slotta-Huspenina, Julia; von Vietinghoff, Sibylle; Viklicky, Ondrej; Green, Douglas R; Rad, Roland; Amann, Kerstin; Linkermann, Andreas; Bräsen, Jan Hinrich; Heemann, Uwe; Kemmner, Stephan.
Afiliação
  • Wahida A; Medical Department III of Hematology and Oncology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Schmaderer C; Department of Nephrology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Büttner-Herold M; Department of Nephropathology, Friedrich-Alexander University (FAU) Erlangen-Nurnberg, Erlangen, Germany.
  • Branca C; Medical Department III of Hematology and Oncology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Donakonda S; Nephropathology Unit, Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Haberfellner F; Department of Nephrology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Torrez C; Department of Nephrology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Schmitz J; Nephropathology Unit, Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Schulze T; Medical Department III of Hematology and Oncology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Seibt T; Transplant Center, University Hospital Munich, Ludwig-Maximilians-University (LMU), Munich, Germany.
  • Öllinger R; Institute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Engleitner T; Institute of Molecular Oncology and Functional Genomics, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Haller B; Institute of AI and Informatics in Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Steiger K; Institute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Günthner R; Department of Nephrology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Lorenz G; Department of Nephrology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Yabal M; Nephropathology Unit, Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Bachmann Q; Department of Nephrology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Braunisch MC; Department of Nephrology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Moog P; Department of Nephrology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Matevossian E; Clinic of General, Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital Munich, Ludwig-Maximilians-University (LMU), Munich, Germany.
  • Aßfalg V; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Thorban S; Institute of Molecular Immunology and Experimental Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Renders L; Department of Nephrology, Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Späth MR; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Müller RU; CECAD, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Stippel DL; Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Weichert W; CECAD, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Slotta-Huspenina J; Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany.
  • von Vietinghoff S; Institute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Viklicky O; Institute of Pathology, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  • Green DR; Nephrology Section, Medical Clinic 1, University Hospital Bonn, Rheinische Friedrich Wilhelm University of Bonn, Bonn, Germany.
  • Rad R; Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Amann K; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Linkermann A; Nephropathology Unit, Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Bräsen JH; Department of Nephropathology, Friedrich-Alexander University (FAU) Erlangen-Nurnberg, Erlangen, Germany.
  • Heemann U; Division of Nephrology, Clinic of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
  • Kemmner S; Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
iScience ; 26(10): 107879, 2023 Oct 20.
Article em En | MEDLINE | ID: mdl-37868627
ABSTRACT
Renal ischemia-reperfusion injury (IRI) is associated with reduced allograft survival, and each additional hour of cold ischemia time increases the risk of graft failure and mortality following renal transplantation. Receptor-interacting protein kinase 3 (RIPK3) is a key effector of necroptosis, a regulated form of cell death. Here, we evaluate the first-in-human RIPK3 expression dataset following IRI in kidney transplantation. The primary analysis included 374 baseline biopsy samples obtained from renal allografts 10 minutes after onset of reperfusion. RIPK3 was primarily detected in proximal tubular cells and distal tubular cells, both of which are affected by IRI. Time-to-event analysis revealed that high RIPK3 expression is associated with a significantly higher risk of one-year transplant failure and prognostic for one-year (death-censored) transplant failure independent of donor and recipient associated risk factors in multivariable analyses. The RIPK3 score also correlated with deceased donation, cold ischemia time and the extent of tubular injury.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2023 Tipo de documento: Article